WeChat Mini Program
Old Version Features

Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma: Real World Data

Burhan Ferhanoglu, Zafer Gulbas,Ant Uzay,Muhit Ozcan,Fahir Ozkalemkas,Mehmet Sinan Dal, Hakan Kalyon,Olga Meltem Akay,Burak Deveci,Huseyin Bekoz,Omur Gokmen Sevindik,Tayfur Toptas,Asu Fergun Yilmaz,Derya Koyun,Nihan Alkis,Elif Birtas Atesoglu

Blood（2022）

Cited 12|Views37
Key words
bispecific antibodies,glofitamab,relapsed,refractory diffuse large B-cell lymphoma
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined